Metabolic Changes of Menopause

  • Lian G. Ulrich


The term menopause is defined as the permanent cessation of menstruation resulting from loss of ovarian follicular activity.1 However, in clinical practice and medical literature, the term menopause is used extensively to describe the years immediately before and after the last menstrual period, viz., the perimenopause or the climacteric. Climacteric is derived from the Latin word climactericus, literally meaning rung of ladder relating to a critical period of life, and this period of a woman’s life is indeed characterized by major biological and psychological changes.


Coronary Heart Disease Postmenopausal Woman Menstrual Cycle High Density Lipoprotein Cholesterol Menopausal Status 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Health Organization. Research on the Menopause. Report of a WHO Scientific Group. WHO Technical Report Series 670. Geneva: WHO, 1981. Google Scholar
  2. 2.
    Richardsson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231–1237.CrossRefGoogle Scholar
  3. 3.
    Lenton EA, Sexton L, Lee S, et al. Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maturitas 1988; 10:35–43.PubMedCrossRefGoogle Scholar
  4. 4.
    Rannevik G, Carlstrom K, Jeppsson S, et al. A prospective long-term study in women from premenopause to postmenopause: changing profiles of gonadotrophins, oestrogens and androgens. Maturitas 1986;8:297–307.PubMedCrossRefGoogle Scholar
  5. 5.
    Longcope C, Franz C, Morello C, et al. Steroid and gonadotropin levels in women during the premenopausal years. Maturitas 1986;8:1989–1996.CrossRefGoogle Scholar
  6. 6.
    Kase NG. The management of the postmenopausal woman. In: Fioretti P, Flamigni C, Jasonni VM, Melis GB, eds. Postmenopausal Hormonal Therapy, Benefits and Risks. New York: Raven Press, 1987:35–54.Google Scholar
  7. 7.
    Metcalf MG, Livesey JH. Pregnanediol excretion in fertile women: age-related changes. J Endocrinol 1988;119:153–157.PubMedCrossRefGoogle Scholar
  8. 8.
    Ross GT Van de Wiele RL. The ovaries and the breasts. Part I The ovaries. In: Williams RH, ed. Textbook of Endocrinology. 6th Ed. Philadelphia: Saunders, 1981:355–399. Google Scholar
  9. 9.
    Nocke W. Some aspects of oogenesis, follicular growth, and endocrine involution. In: Greenblatt RB, ed. A Modern Approach to the Perimenopausal Years. New York: de Gruyter, 1986:11–38.Google Scholar
  10. 10.
    Jensen J, Riis BJ, Hummer L, et al. The effects of age and body composition on circulating serum oestrogens and androstenedione after the menopause. Br J Obstet Gynaecol 1985;92:260–265.PubMedCrossRefGoogle Scholar
  11. 11.
    Carlstrom K, Brody S, Lunell N-O, et al. Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 1988;10:297–306.PubMedCrossRefGoogle Scholar
  12. 12.
    Jensen J, Nilas L, Christiansen C. Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br J Obstet Gynaecol 1986;93:613–618.PubMedCrossRefGoogle Scholar
  13. 13.
    Knopp RH. Cardiovascular effects of endogenous and exogenous sex hormones over a woman’s lifetime. Am J Obstet Gynaecol 1988;158:1630–1643.Google Scholar
  14. 14.
    Jones DY, Judd T, Taylor PR, et al. Menstrual cycle effect on plasma lipids. Metabolism 1988;37:1–2.PubMedCrossRefGoogle Scholar
  15. 15.
    Woods M Schaefer E Morrill A et al. Effect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab 1987;65:321–323.Google Scholar
  16. 16.
    Cullinane EM, Sody M, Mitcheson S, et al. Variations in plasma volume alter total and LDL-cholesterol concentration during the menstrual cycle. Abstract 1535. Circulation 1988;78(Suppl): II-385. Google Scholar
  17. 17.
    Lewis B, Chait A, Wooton IDP, et al. Frequency of risk factors for ischaemic heart disease in a healthy British population. Lancet 1974;1:141–146.PubMedCrossRefGoogle Scholar
  18. 18.
    Mann JI, Lewis B, Shepherd J, et al. Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence and detection in Britain. Br Med J 1988;296:1702–1706.CrossRefGoogle Scholar
  19. 19.
    Kannel WB, Gordon T. Cardiovascular effects of the menopause. In: Mishell DR, Jr, ed. Menopause: Physiology and Pharmacology. Chicago: Year Book Medical Pulishers, 1987:91–102.Google Scholar
  20. 20.
    Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distributions in selected North American populations. The Lipid Research Clinics Program Prevalence Study. Circulation 1979;60:427–439.Google Scholar
  21. 21.
    Heiss G, Tannis I, Davies CE, et al. Lipoprotein cholesterol distributions in selected North American populations: The Lipid Research Clinics Program Prevalence Study. Circulation 1980;61:302–315.PubMedGoogle Scholar
  22. 22..
    Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553–1560.PubMedGoogle Scholar
  23. 23.
    Wentz AC. Management of the menopause. In: Jones HW, Wentz AC, Burnett LS, eds. Novak’s Textbook of Gynecology. 11th Edition. Baltimore: Williams & Wilkins. Google Scholar
  24. 24.
    Johansson S, Vedin A, Wilhelmsson C. Myocardial infarction in women. Epidemiol Rev 1983;5:67–95.PubMedGoogle Scholar
  25. 25.
    Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36–69.CrossRefGoogle Scholar
  26. 26.
    Gordon T, Kannel WB, Hjortland ML, et al. Menopause and coronary heart disease. Ann Intern Med 1978;89:157–161.PubMedGoogle Scholar
  27. 27.
    Colditz GA, Willett WC, Stampfer MJ, et al. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105–1110.PubMedCrossRefGoogle Scholar
  28. 28.
    Bengtsson, Lundquist O. Coronary heart disease during the menopause. In: Oliver MF, ed. Coronary Heart disease in Young Women. New York: Churchill Livingstone, 1978;234–239. Google Scholar
  29. 29.
    Aranvantinos DJ. Keeping or removing the ovaries at the time of hysterectomy. Eur J Obstet & Gynecol Reproduct Biol 1988;28:140–146.CrossRefGoogle Scholar
  30. 30.
    Goldbaum, GM Kendrick JS, Hogelin GC, et al. The behavioural risk factor surveys group: the relative impact of smoking on oral contraceptive use on women in the United Stats. JAMA 1987;258:1339–1342.PubMedCrossRefGoogle Scholar
  31. 31.
    Andersen FJ, Transbol I, Christiansen C. Is smoking a promoter of the menopause? Acta Med Scand 1982;212:137–139.PubMedCrossRefGoogle Scholar
  32. 32.
    Khaw K-T, Tazuke S, Barret-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 1988;318:1705–1709.PubMedCrossRefGoogle Scholar
  33. 33.
    Oliver MF, Boyd GS. Effect of bilateral ovariectomy on coronary artery disease and serum lipid levels. Lancet 1959;2:690–694.PubMedCrossRefGoogle Scholar
  34. 34.
    Robinson RW, Higano N, Cohen WD. Increased incidence of coronary heart disease in women castrated prior to menopause. Arch Intern Med 1959; 104:908–913.PubMedGoogle Scholar
  35. 35.
    Notelovitz M, Gudat JC, Ware MD, et al. Lipids and lipoproteins in women after oophorectomy and the response to estrogen therapy. Br J Obstet Gynaecol 1983;90:171–177.PubMedCrossRefGoogle Scholar
  36. 36.
    Johansson BW, Kaij L, Kullander S, et al. On some late effects of bilateral oophorectomy in the age range 15–30 years. Acta Obstet Gynecol Scand 1975;54:449–461.PubMedCrossRefGoogle Scholar
  37. 37.
    Hallberg L, Svanborg A. Cholesterol, phospholipids and triglycerides in plasma in 50 year-old women. Acta Med Scand 1967;181:185–194.PubMedCrossRefGoogle Scholar
  38. 38.
    Bengtsson C, Rybo G, Westerberg H. Ischaemic heart disease in women. Acta Med Scand [Suppl] 1973;549:75–81.Google Scholar
  39. 39.
    Campos H, McNamara JR, Wilson PWF, et al. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Metab 1988;67:30–35.PubMedCrossRefGoogle Scholar
  40. 40.
    Matthews KA, Wing RR, Meilahn EN, et al. Menopause influences risk factors for coronary heart disease. Abstract 2325. Circulation 1988;78(Suppl): II-583 (Suppl)II, Vol.78, no4.October 1988. Google Scholar
  41. 41.
    Notelovitz M, Kitchens CS, Rappaport V, et al. Menopausal status associated with increased inhibition of blood coagulation. Am J Obstet Gynecol 1981;141:149–152.PubMedGoogle Scholar
  42. 42.
    Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease. JAMA 1987;258:1183–1186.PubMedCrossRefGoogle Scholar
  43. 43.
    Teichmann AT. Age, metabolism and oral contraception. Maturitas 1988; (Suppl I): 117–130. Google Scholar
  44. 44.
    De Aloysio D, Villeco AS, Fabiani AG, et al. Body mass index distribution inclimacteric women. Maturitas 1988;9:359–366. Google Scholar
  45. 45.
    Rainville S, Vaccaro P. The effects of menopause and training on serum lipids. Int J Sports Med 1984;5:137–141.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1991

Authors and Affiliations

  • Lian G. Ulrich

There are no affiliations available

Personalised recommendations